Forgetfulness: a role in noncompliance with antidepressant treatment
- PMID: 17121172
- DOI: 10.1177/070674370605101110
Forgetfulness: a role in noncompliance with antidepressant treatment
Abstract
Objectives: To determine the degree of noncompliance with antidepressant treatment in the Alberta population and to investigate the reasons for noncompliance.
Method: We used data from the Alberta Mental Health Survey, a telephone survey conducted in 2003 (n = 5323 adults), to produce population-based estimates of the frequency of noncompliance and the reported reasons for noncompliance.
Results: Reported noncompliance was 41.7% (95% confidence interval [CI], 36.9% to 46.6%) for respondents taking 1, 2, or 3 antidepressants. Noncompliance for those taking 1 antidepressant was 42.0% (95%CI, 36.9% to 47.2%), whereas noncompliance for those taking 2 or 3 antidepressants was 39.4% (95%CI, 26.7% to 53.6%). Among respondents currently taking at least one antidepressant, 64.9% (95%CI, 57.4% to 71.7%) reported that forgetfulness was the most common reason for noncompliance. Of respondents taking 1 medication, 64.1% (95%CI, 56.0% to 71.4%) reported forgetfulness as did 71.3% (95%CI, 48.3% to 86.8%) of those taking 2 or 3 medications. Both the frequency of noncompliance and the reported reasons for noncompliance were independent of sex and age.
Conclusion: Our study replicates prior reports that indicate that noncompliance is common with antidepressant treatment. Forgetting to take medication is the most important reported reason for this noncompliance.
Similar articles
-
[Antidepressants consumption in the global population in France].Encephale. 2002 Sep-Oct;28(5 Pt 1):411-7. Encephale. 2002. PMID: 12386542 French.
-
Non-remission of depression in the general population as assessed by the HAMD-7 scale.Depress Anxiety. 2008;25(5):393-7. doi: 10.1002/da.20396. Depress Anxiety. 2008. PMID: 17948276
-
Frequency and adequacy of depression treatment in a Canadian population sample.Can J Psychiatry. 2007 Dec;52(12):780-9. doi: 10.1177/070674370705201205. Can J Psychiatry. 2007. PMID: 18186178
-
Frequency of antidepressant use in relation to recent and past major depressive episodes.Can J Psychiatry. 2010 Aug;55(8):532-5. doi: 10.1177/070674371005500808. Can J Psychiatry. 2010. PMID: 20723281
-
Adherence to antidepressant treatment.Expert Rev Neurother. 2007 Jan;7(1):57-62. doi: 10.1586/14737175.7.1.57. Expert Rev Neurother. 2007. PMID: 17187497 Review.
Cited by
-
Assessing patient preferences for delivery of reminders on scheduled visits in a psychiatry ambulatory service.AMIA Annu Symp Proc. 2007 Oct 11;2007:776-80. AMIA Annu Symp Proc. 2007. PMID: 18693942 Free PMC article.
-
Assessing forgetfulness and polypharmacy and their impact on health-related quality of life among patients with hypertension and dyslipidemia in Greece during the COVID-19 pandemic.Qual Life Res. 2022 Jan;31(1):193-204. doi: 10.1007/s11136-021-02917-y. Epub 2021 Jun 22. Qual Life Res. 2022. PMID: 34156596 Free PMC article.
-
Non-adherence with psychotropic medications in the general population.Soc Psychiatry Psychiatr Epidemiol. 2010 Jan;45(1):47-56. doi: 10.1007/s00127-009-0041-5. Epub 2009 Apr 4. Soc Psychiatry Psychiatr Epidemiol. 2010. PMID: 19347238
-
Depression, medication adherence, and service utilization in systemic lupus erythematosus.Arthritis Rheum. 2009 Feb 15;61(2):240-6. doi: 10.1002/art.24236. Arthritis Rheum. 2009. PMID: 19177526 Free PMC article.
-
Factors that influence adherence with disease-modifying therapy in MS.J Neurol. 2009 Apr;256(4):568-76. doi: 10.1007/s00415-009-0096-y. Epub 2009 Apr 27. J Neurol. 2009. PMID: 19444532
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical